Optimizing Medication Access and Use in Inflammatory Bowel Disease: The Roles and Impact of Clinical Pharmacists and Pharmacy Technicians-Reference-Cited by-同舟云学术

Optimizing Medication Access and Use in Inflammatory Bowel Disease: The Roles and Impact of Clinical Pharmacists and Pharmacy Technicians

Published:2023-03-09 Issue:2 Volume:5 Page:
ISSN:2631-827X
Container-title:Crohn's & Colitis 360
language:en
Short-container-title:

Author:

Bhat Shubha¹²^ORCID

Affiliation:

1. Department of Pharmacy, Cleveland Clinic Foundation , Cleveland, Ohio , USA

2. Digestive Disease & Surgery Institute, Cleveland Clinic Foundation , Cleveland, Ohio , USA

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology

Link

https://academic.oup.com/crohnscolitis360/advance-article-pdf/doi/10.1093/crocol/otad014/49468060/otad014.pdf

Reference12 articles.

1. Health-risk behaviors and chronic conditions among adults with inflammatory bowel disease—United States, 2015 and 2016;Xu;MMWR Morb Mortal Wkly Rep.,2018

2. Prevalence of inflammatory bowel disease in pediatric and adult populations: recent estimates from large national databases in the United States, 2007–2016;Ye;Inflamm Bowel Dis.,2020

3. AGA clinical practice guidelines on the medical management of moderate to severe luminal and perianal fistulizing Crohn’s disease;Feuerstein;Gastroenterology.,2021

4. AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis;Feuerstein;Gastroenterology.,2020

5. The cost of inflammatory bowel disease: an initiative from the Crohn’s & Colitis Foundation;Park;Inflamm Bowel Dis.,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How can pharmacists better support patients with chronic diseases? The patient perspective;Journal of the American Pharmacists Association;2023-11